Journal article

Brain catecholamine depletion and motor impairment in a Th knock-in mouse with type B tyrosine hydroxylase deficiency

  • Korner, Germaine Division of Metabolism, Department of Paediatrics, University of Zürich, Switzerland - Affiliated with the Neuroscience Centre Zurich ZNZ, Zürich, Switzerland - Affiliated with the Children’s Research Centre CRC, Zürich, Switzerland
  • Noain, Daniela Department of Neurology, University Hospital of Zurich, Zürich, Switzerland
  • Ying, Ming Department of Biomedicine, University of Bergen, Bergen, Norway
  • Hole, Magnus Department of Biomedicine, University of Bergen, Bergen, Norway
  • Flydal, Marte I. Department of Biomedicine, University of Bergen, Bergen, Norway
  • Scherer, Tanja Division of Metabolism, Department of Paediatrics, University of Zürich, Switzerland - Affiliated with the Children’s Research Centre CRC, Zürich, Switzerland
  • Allegri, Gabriella Division of Metabolism, Department of Paediatrics, University of Zürich, Switzerland - Affiliated with the Children’s Research Centre CRC, Zürich, Switzerland
  • Rassi, Anahita Division of Clinical Chemistry and Biochemistry, Department of Paediatrics, University of Zürich, Switzerland
  • Fingerhut, Ralph Swiss Newborn Screening Laboratory, University Children’s Hospital, Zurich, Switzerland - Affiliated with the Children’s Research Centre CRC, Zürich, Switzerland
  • Becu-Villalobos, Damasia Institute of Biology and Experimental Medicine, Buenos Aires, Argentina
  • Pillai, Samyuktha Institute of Physiology, University of Zurich, Switzerland
  • Wueest, Stephan Affiliated with the Children’s Research Centre CRC, Zürich, Switzerland - Division of Endocrinology, Department of Pediatrics, University of Zurich, Switzerland
  • Konrad, Daniel Affiliated with the Children’s Research Centre CRC, Zürich, Switzerland - Division of Endocrinology, Department of Pediatrics, University of Zurich, Switzerland
  • Lauber-Biason, Anna Department of Medicine, University of Fribourg, Switzerland
  • Baumann, Christian R. Affiliated with the Neuroscience Centre Zurich ZNZ, Zürich, Switzerland - Department of Neurology, University Hospital of Zurich, Zürich, Switzerland
  • Bindoff, Laurence A. Department of Clinical Medicine K1, University of Bergen, Norway - Department of Neurology, Haukeland University Hospital, Bergen, Norway
  • Martinez, Aurora Department of Biomedicine, University of Bergen, Bergen, Norway
  • Thöny, Beat Division of Metabolism, Department of Paediatrics, University of Zürich, Switzerland - Affiliated with the Neuroscience Centre Zurich ZNZ, Zürich, Switzerland - Affiliated with the Children’s Research Centre CRC, Zürich, Switzerland
Show more…
    01.10.2015
Published in:
  • Brain. - 2015, vol. 138, no. 10, p. 2948-2963
English Tyrosine hydroxylase catalyses the hydroxylation of L-tyrosine to l-DOPA, the rate- limiting step in the synthesis of catecholamines. Mutations in the TH gene encoding tyrosine hydroxylase are associated with the autosomal recessive disorder tyrosine hydroxylase deficiency, which manifests phenotypes varying from infantile parkinsonism and DOPA-responsive dystonia, also termed type A, to complex encephalopathy with perinatal onset, termed type B. We generated homozygous Th knock-in mice with the mutation Th-p.R203H, equivalent to the most recurrent human mutation associated with type B tyrosine hydroxylase deficiency (TH-p.R233H), often unresponsive to l-DOPA treatment. The Th knock-in mice showed normal survival and food intake, but hypotension, hypokinesia, reduced motor coordination, wide-based gate and catalepsy. This phenotype was associated with a gradual loss of central catecholamines and the serious manifestations of motor impairment presented diurnal fluctuation but did not improve with standard l-DOPA treatment. The mutant tyrosine hydroxylase enzyme was unstable and exhibited deficient stabilization by catecholamines, leading to decline of brain tyrosine hydroxylase-immunoreactivity in the Th knock-in mice. In fact the substantia nigra presented an almost normal level of mutant tyrosine hydroxylase protein but distinct absence of the enzyme was observed in the striatum, indicating a mutation-associated mislocalization of tyrosine hydroxylase in the nigrostriatal pathway. This hypomorphic mouse model thus provides understanding on pathomechanisms in type B tyrosine hydroxylase deficiency and a platform for the evaluation of novel therapeutics for movement disorders with loss of dopaminergic input to the striatum.
Faculty
Faculté des sciences et de médecine
Department
Médecine 3ème année
Language
  • English
Classification
Biology
License
License undefined
Identifiers
Persistent URL
https://folia.unifr.ch/unifr/documents/304659
Statistics

Document views: 7 File downloads:
  • awv224.pdf: 1